| | Class 2 Device Recall MIVI Super 90 Guide Catheters |  |
| Date Initiated by Firm | July 23, 2021 |
| Create Date | September 09, 2021 |
| Recall Status1 |
Terminated 3 on May 23, 2024 |
| Recall Number | Z-2441-2021 |
| Recall Event ID |
88408 |
| 510(K)Number | K151396 |
| Product Classification |
Catheter, percutaneous - Product Code DQY
|
| Product | MIVI Super 90 Guide Catheters, MIVI Mi-Axus 8F Catheters, REF MIA-9080S (80 cm length); MIA-9090S (90 cm length), and MIA-9095S (95 cm length), MIA-9080-E, MIA-9090S-E, MIA-9095S-E, Sterile.
Device is used to facilitate the insertion and guidance of microcatheters into a selected blood vessel in the peripheral, coronary and neuro vascular systems. |
| Code Information |
Cat. #MIA-9095S - Lots M20090013, exp. 9/10/2021; and M20110008, 10/26/2021.
Cat. #MIA-9095S-E - Lots M20090012, exp. 9/10/2021; M20110007, exp. 10/26/2021; M21030017, exp. 10/26/2023; M21030018, exp. 9/10/2023; M21040003, exp. 4/24/2024; M21050014, exp. 1/27/2023; M21050015, exp. 1/27/2023; M21060002, exp. 2/7/2023; and M21060003, exp. 3/12/2023.
Cat. #MIA-9090S - Lot M20110006, exp. 10/27/2021.
Cat. #MIA-9090S-E - Lots M20080005, exp.8/6/2021; M20090011, exp. 9/10/2021; M20110005, exp. 10/27/2021; M21010008, exp. 12/10/2021; M21030014, exp.12/10/2023; M21030015, exp. 12/10/2023; M21050013, exp. 12/10/2023; M21060006, exp. 4/3/2022; M21060007, exp. 10/30/2022; M21060008, exp. 10/30/2022; M21060009, exp. 1/27/2023; M21060010, exp. 1/27/2023; M21060011, exp. 3/12/2023; and M21060012, exp. 12/10/2023.
Cat. #MIA9080S - Lot M20110009, exp. 10/27/2021.
Cat. #MIA 9080S-E - Lots M21010011, exp. 12/10/2021; M21030005, exp. 10/27/2023; M21030013, exp. 4/30/2023; M21060014, exp. 10/10/2022; M21060015, exp. 10/22/2022;
M21060016, exp. 4/30/2023; and M21060017, exp. 12/10/2023.
|
| FEI Number |
3011410509
|
Recalling Firm/ Manufacturer |
Mivi Neuroscience Inc 6545 City West Pkwy Eden Prairie MN 55344-3248
|
| For Additional Information Contact | Mr. Randy LaBounty 952-944-3834 |
Manufacturer Reason for Recall | There is potential for nonsterility of product due to a possible defect in the pouch seal. |
FDA Determined Cause 2 | Packaging |
| Action | The recalling firm, MIVI Neuroscience, Inc., first notified clinical study sites of the recall by memo dated 7/23/2021 issued via email on 7/23/2021.The memo instructed the investigational study site to quarantine and return all of the affected catheters in their EVAQ Clinical Trial inventory. The site was informed the recalling firm is working to resolve the issue to provide replacement units to continue enrolling in the EVAQ Trial. They were instructed to not enroll any subjects until replacements are received.
The recalling firm issued letters to their commercial customers dated 8/2/2021 on 8/2/2021 via email and certified mail. The customers were instructed to do the follow: Immediately examine your inventory and quarantine all products subject to this recall. All quarantined products should be returned to MIVI Neuroscience.
2. Please complete the Medical Device Recall Return Response attached.
3. Return the response form no later than 28 August 2021 to customerservice@mivineuro.com.
4. Return your unused inventory listed on the response form to the address listed below with the Return Authorization: RA66.
5. We will issue a credit for the devices returned.
If you have any questions, contact VP Quality, Regulator and Clinical at (952) 944-3834 or email: customerservice@minineuro.com Monday through Friday 8:00am to 4:30pm, Central Time. |
| Quantity in Commerce | 491 units |
| Distribution | US Distribution to states of: FL, MA, NJ, NY, and TN; and OUS (Foreign) distribution to countries of: France, Hungary, Slovenia, and Spain. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = DQY
|
|
|
|